DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8

Cancer Science

Volumn 101, Issue 6, 2010, Pages 1431-1439

  Kurita, Satoshi ^a,b   Higuchi, Hajime ^a   Saito, Yoshimasa ^a   Nakamoto, Nobuhiro ^a   Takaishi, Hiromasa ^a   Tada, Shinichiro ^a   Saito, Hidetsugu ^a   Gores, Gregory J ^b   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY   (Japan)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DEATH RECEPTOR 5; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; GENE SILENCING; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 8; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; GENE SILENCING; HUMANS; LIVER NEOPLASMS; MITOCHONDRIAL PROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 77954173416     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01565.x     Document Type: Article

References (45)

1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-28.
2. Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, Barlow DP. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 1997, 389:745-9.
3. Stoger R, Kubicka P, Liu CG. Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 1993, 73:61-71.
4. Counts JL, Goodman JI. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 1995, 83:13-5.
5. Warnecke PM, Bestor TH. Cytosine methylation and human cancer. Curr Opin Oncol 2000, 12:68-73.
6. Bird A. DNA methylation de novo. Science 1999, 286:2287-8.
7. Jones PA. DNA methylation errors and cancer. Cancer Res 1996, 56:2463-7.
8. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999, 21:163-7.
9. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000, 9:2395-402.
10. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-57.
11. Rhee I, Jair KW, Yen RW. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 2000, 404:1003-7.
12. Rhee I, Bachman KE, Park BH. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002, 416:552-6.
13. Leu YW, Rahmatpanah F, Shi H. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res 2003, 63:6110-5.
14. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 2001, 33:561-8.
15. Saito Y, Kanai Y, Nakagawa T. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 2003, 105:527-32.
16. van Noesel MM, van Bezouw S, Salomons GS. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. Cancer Res 2002, 62:2157-61.
17. Teitz T, Wei T, Valentine MB. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000, 6:529-35.
18. Higuchi H, Yoon JH, Grambihler A, Werneburg N, Bronk SF, Gores GJ. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis. J Biol Chem 2003, 278:454-61.
19. Li X, Hui AM, Sun L. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res 2004, 10:7484-9.
20. Schagdarsurengin U, Wilkens L, Steinemann D. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene 2003, 22:1866-71.
21. Yu J, Ni M, Xu J. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002, 2:29.
22. Fulda S, Debatin KM. 5-Aza-2′-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 2006, 25:5125-33.
23. Martinez R, Setien F, Voelter C. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 2007, 28:1264-8.
24. Ramchandani S, MacLeod AR, Pinard M, von Hofe E, Szyf M. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynu-cleotide. Proc Natl Acad Sci U S A 1997, 94:684-9.
25. Robert MF, Morin S, Beaulieu N. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 2003, 33:61-5.
26. Ting AH, Jair KW, Suzuki H, Yen RW, Baylin SB, Schuebel KE. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Nat Genet 2004, 36:582-4.
27. Suzuki M, Sunaga N, Shames DS, Toyooka S, Gazdar AF, Minna JD. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 2004, 64:3137-43.
28. Ting AH, Jair KW, Schuebel KE, Baylin SB. Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation. Cancer Res 2006, 66:729-35.
29. Beaulieu N, Morin S, Chute IC, Robert MF, Nguyen H, MacLeod AR. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem 2002, 277:28176-81.
30. Palakurthy RK, Wajapeyee N, Santra MK. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol Cell 2009, 36:219-30.
31. Nagai M, Nakamura A, Makino R, Mitamura K. Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas. Hepatol Res 2003, 26:186-91.
32. Fuks F, Hurd PJ, Deplus R, Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 2003, 31:2305-12.
33. Lehnertz B, Ueda Y, Derijck AA. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003, 13:1192-200.
34. Foltz G, Yoon JG, Lee H. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis. Oncogene 2009, 28:2667-77.
35. Milutinovic S, Zhuang Q, Niveleau A, Szyf M. Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J Biol Chem 2003, 278:14985-95.
36. Milutinovic S, Brown SE, Zhuang Q, Szyf M. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. J Biol Chem 2004, 279:27915-27.
37. Takimoto R, El-Deiry WS. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 2000, 19:1735-43.
38. Meng RD, El-Deiry WS. p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma. Exp Cell Res 2001, 262:154-69.
39. Higuchi H, Grambihler A, Canbay A, Bronk SF, Gores GJ. Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 2004, 279:51-60.
40. Fandy TE, Shankar S, Ross DD, Sausville E, Srivastava RK. Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma. Neoplasia 2005, 7:646-57.
41. Hopkins-Donaldson S, Ziegler A, Kurtz S. Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ 2003, 10:356-64.
42. Eramo A, Pallini R, Lotti F. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction. Cancer Res 2005, 65:11469-77.
43. Liedtke C, Zschemisch NH, Cohrs A. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element. Gastroenterology 2005, 129:1602-15.
44. Nguyen CT, Weisenberger DJ, Velicescu M. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res 2002, 62:6456-61.
45. Kondo Y, Shen L, Issa JP. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 2003, 23:206-15.